Liver immune-related adverse effects of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors: a propensity score matched study with competing risk analyses

Zhou, J., Chau, Y.-L.A., Yoo, J.W., Lee, S., Ng, K., Dee, E.C., Liu, T., Wai, A.K.C., Zhang, Q., Tse, Gary and others. (2022) Liver immune-related adverse effects of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors: a propensity score matched study with competing risk analyses. Clinical Oncology, 34 (7). e316-e317. ISSN 0936-6555. (doi:10.1016/j.clon.2022.03.006) (Access to this publication is currently restricted. You may be able to access a copy if URLs are provided) (KAR id:98718)

PDF Publisher pdf Language: English Restricted to Repository staff only
Contact us about this Publication
Official URL: https://www.clinicaloncologyonline.net/article/S09...

Item Type:	Article
DOI/Identification number:	10.1016/j.clon.2022.03.006
Subjects:	R Medicine > R Medicine (General)
Divisions:	Divisions > Division of Natural Sciences > Kent and Medway Medical School
Funders:	University of Kent (https://ror.org/00xkeyj56)
Depositing User:	Manfred Gschwandtner
Date Deposited:	05 Dec 2022 17:44 UTC
Last Modified:	14 Dec 2022 14:01 UTC
Resource URI:	https://kar.kent.ac.uk/id/eprint/98718 (The current URI for this page, for reference purposes)

University of Kent Author Information

Tse, Gary.

Creator's ORCID:	https://orcid.org/0000-0001-5510-1253
CReDIT Contributor Roles:

Depositors only (login required):

Altmetric

Download Statistics

Total unique views for this document in KAR since July 2020. For more details click on the image.